Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM

Autologous stem cell transplantation (ASCT) followed by lenalidomide maintenance therapy is the standard of care for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM). Clinical trials show progression-free survival (PFS) benefits, with some studies (Cancer and Leukemia Group...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Jagannath, Sundar, Abonour, Rafat, Durie, Brian G. M., Narang, Mohit, Terebelo, Howard R., Gasparetto, Cristina J., Toomey, Kathleen, Hardin, James W., Wagner, Lynne, Agarwal, Amit, Srinivasan, Shankar, Kitali, Amani, Flick, E. Dawn, Sturniolo, Michael, Rifkin, Robert M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6039656/
https://ncbi.nlm.nih.gov/pubmed/29986853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018017186
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados